Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes

BACKGROUND: Uncertainty lingers about optimal monotherapy initiation for hypertension. Recent guidelines recommend starting any primary agent among five first-line drug classes, thiazide or thiazide-like diuretics (THZ), angiotensin converting-enzyme inhibitors (ACEi), angiotensin receptor blockers,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Lancet
Egile Nagusiak: Suchard, Marc A., Schuemie, Martijn J., Krumholz, Harlan M., You, Seng Chan, Chen, RuiJun, Pratt, Nicole, Reich, Christian G., Duke, Jon, Madigan, David, Hripcsak, George, Ryan, Patrick B.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6924620/
https://ncbi.nlm.nih.gov/pubmed/31668726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(19)32317-7
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak